Neuralink — billionaire Elon Musk's brain-chip startup — announced Tuesday that its experimental implant for restoring vision in patients, titled Telepathy, had received the US Food and Drug Administration's (FDA) "breakthrough device" designation.
Neuralink's Telepathy Receives FDA 'Breakthrough' Tag